For women with polycystic ovary syndrome (PCOS), a condition closely linked to insulin resistance and obesity, GLP-1-based therapies have shown some promise in improving hormonal profiles, reducing androgen levels, and restoring menstrual regularity
It aids muscle soreness and recovery after exercise when taken as a post-workout supplement
How it works mechanism of action Retatrutide is the only triple agonist GLP-1 + GIP + glucagon
The margin between correct and incorrect is narrow, and errors don't announce themselves
The transcript may contain errors and is not a substitute for watching the video
Li Y, Li A, Glas M, Lal B, Ying M, Sang Y, Xia S, Trageser D, Guerrero-Cazares H, Eberhart CG, et al